ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.122,25
0,95%
S&P 500
5.064,20
0,91%
US Dollar vs BRL
5,111
-0,02%
Bitcoin
59.338,98
0,37%
Brent Oil
83,905
0,33%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Osmotica Pharmaceuticals PLC (OSMT)

  7. Osmotica Pharmaceuticals PLC (OSMT) Notícias

OSMT

Osmotica Pharmaceuticals (OSMT)

Osmotica Pharmaceuticals PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSMT
DataHoraFonteTítuloCódigoCompanhia
16/06/202317:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/05/202317:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202317:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/03/202318:26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
27/01/202318:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
26/01/202319:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/08/202217:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/202216:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/202218:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/04/202218:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
30/03/202217:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202213:38GlobeNewswire Inc.UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202208:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
18/01/202208:50GlobeNewswire Inc.RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/01/202210:55GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
23/12/202108:15TipRanksH.C. Wainwright Thinks Osmotica Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OSMTOsmotica Pharmaceuticals PLC
20/12/202118:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
16/11/202119:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202118:05GlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202108:50GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/11/202121:30GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/10/202117:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
13/10/202117:45GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/10/202118:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202110:04GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202101:31GlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/10/202117:26GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/09/202118:00GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:OSMT

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BBDC4
BRADESCO PN
BOV
PRIO3
PETRORIO ON
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
BEES3
BANESTES ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados